ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,162.52
0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Arch Therapeutics Inc (QB) (ARTH)

  7. Arch Therapeutics Inc (QB) (ARTH) News

Arch Therapeutics (QB) (ARTH)

Arch Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ARTH
DateTimeSourceHeadlineSymbolCompany
22/06/202321:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
23/05/202311:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
16/05/202311:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARTHArch Therapeutics Inc (QB)
20/04/202321:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
17/03/202310:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
09/03/202313:08Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
07/03/202314:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
16/02/202311:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
14/02/202321:48Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
25/01/202320:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARTHArch Therapeutics Inc (QB)
23/01/202322:18Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
17/01/202321:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
28/12/202221:52Edgar (US Regulatory)Annual Report (10-k)USOTC:ARTHArch Therapeutics Inc (QB)
02/12/202212:26Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
30/09/202221:37Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARTHArch Therapeutics Inc (QB)
31/08/202211:05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202222:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:ARTHArch Therapeutics Inc (QB)
30/08/202211:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARTHArch Therapeutics Inc (QB)
26/08/202211:09Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARTHArch Therapeutics Inc (QB)
22/08/202211:04Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARTHArch Therapeutics Inc (QB)
18/08/202211:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARTHArch Therapeutics Inc (QB)
17/08/202221:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202221:24Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202221:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
15/08/202221:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
11/08/202222:24Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARTHArch Therapeutics Inc (QB)
11/07/202222:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
11/07/202222:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
11/07/202222:25Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARTHArch Therapeutics Inc (QB)
08/07/202222:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARTHArch Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:ARTH

Your Recent History

LSE
PANR
Pantheon Resources
LSE
AAZ
Anglo Asian Mining
LSE
SDRY
Superdry
LSE
PHNX
Phoenix
LSE
AFC
Afc Energy
LSE
ENET
Ethernity Networks
LSE
HUM
Hummingbird Resources
LSE
GPM
Golden Prospect Precious...
LSE
HE1
Helium One Global
LSE
SRSP
Sirius Petroleum
LSE
JIM
Jarvis Securities
LSE
IES
Invinity Energy Systems
LSE
INSG
Insig Ai
LSE
PCIP
Pci-pal
LSE
FUM
Futura Medical
LSE
VOD
Vodafone
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved